Overall, our data demonstrated that the inhibition of TBK1 could downregulate the level of inflammation in the SDH of PDN mice, inhibiting microglial pyroptosis, alleviating peripheral nerve injury, and finally reducing hyperalgesia. This evidence concerns the gene TBK1 and peripheral nerve injury.